{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:16:41Z","timestamp":1780438601295,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003429.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T00:00:00Z","timestamp":1315353600000}}],"reference-count":57,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003429.pub4","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T14:49:10Z","timestamp":1314802150000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B"],"prefix":"10.1002","author":[{"given":"Alfonso","family":"Iorio","sequence":"first","affiliation":[{"name":"McMaster University; Clinical Epidemiology and Biostatistic Department; 1280 Main Street West CRL - 140 Hamilton ON Canada L8S 4K1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Marchesini","sequence":"additional","affiliation":[{"name":"University of Perugia; Department of Internal Medicine; Ospedale Santa Maria della Misericordia Localit\u00e0 Sant'Andrea delle Fratte Perugia Italy 06126"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Marcucci","sequence":"additional","affiliation":[{"name":"University of Perugia; Department of Internal Medicine; Ospedale Santa Maria della Misericordia Localit\u00e0 Sant'Andrea delle Fratte Perugia Italy 06126"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Stobart","sequence":"additional","affiliation":[{"name":"University of Alberta; Northern Alberta Children's Cancer Program, Department of Pediatrics; Room 7327A Aberhart Centre 11402 University Avenue NW Edmonton Alberta Canada T6G 2J3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony KC","family":"Chan","sequence":"additional","affiliation":[{"name":"McMaster University; Division of Pediatric Hematology\/Oncology, Health Sciences Centre; 1200 Main Street West Hamilton Ontario Canada L8N 3Z5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,7]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1976.tb00973.x","article-title":"Prophylaxis in hemophilia: a double-blind controlled trial","volume":"33","author":"Aronstam","year":"1976","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jcp.30.1.65","article-title":"Twice weekly prophylactic therapy in haemophilia A","volume":"30","author":"Aronstam","year":"1977","journal-title":"Journal of Clinical Pathology"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2516.1997.00091.x","article-title":"Improved cost-effectiveness by pharmacokinetic dosing of factor VIIII in prophylactic treatment of haemophilia A","volume":"3","author":"Carlsson","year":"1997","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1538-7836.2011.04214.x","article-title":"A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study)","volume":"9","author":"Gringeri","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7","key":"10.1002\/14651858.CD003429.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPH.0b013e318068b1d6","article-title":"Central venous access device infections in children with hemophilia","volume":"29","author":"Hacker","year":"2007","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"6","key":"10.1002\/14651858.CD003429.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0609.1976.tb01115.x","article-title":"Evaluation of prophylactic replacement therapy in haemophilia B","volume":"16","author":"Morfini","year":"1976","journal-title":"Scandinavian Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","article-title":"A longitudinal study of orthopaedic outcomes for severe factor VIII deficient haemophiliacs","volume":"236","author":"Aledort","year":"1994","journal-title":"Journal of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2141.1999.01463.x","article-title":"Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized","volume":"105","author":"Astermark","year":"1999","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD003429.pub4-BIB0010|cit10","first-page":"251","article-title":"Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12 years of experience","volume":"22","author":"Brackmann","year":"1992","journal-title":"Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0011|cit11","first-page":"243","article-title":"Prophylactic treatment for haemophilia A patients:a pilot study","volume":"26","author":"Chuansumrit","year":"1995","journal-title":"Southeast Asian Journal of Tropical Medicine of Public Health"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1538-7836.2009.03650.x","article-title":"Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study","volume":"8","author":"Collins","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/shem.2001.26299","article-title":"Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients","volume":"38","author":"Courter","year":"2001","journal-title":"Seminars in Hematology"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1055\/s-0038-1650635","article-title":"Radiological score in paediatric haemophilic patients with early and late onset of factor VIII-prophylaxis","volume":"76","author":"Dzinaj","year":"1996","journal-title":"Thrombosis Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD003429.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1538-7836.2006.01953.x","article-title":"Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study","volume":"4","author":"Feldman","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003429.pub4-BIB0016|cit16","first-page":"OR205","article-title":"Late prophylaxis for severe hemophilia: effects of prophylaxis started in adulthood [abstract]","volume":"3","author":"Fischer","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/08880019709030901","article-title":"Prophylactic therapy for hemophilia in a developing country, Turkey","volume":"14","author":"Kavakli","year":"1997","journal-title":"Pediatric Hematology and Oncology"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2516.1998.440413.x","article-title":"When should prophylactic treatment in patients with haemophilia A and B start?- The German experience","volume":"4","author":"Kreuz","year":"1998","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2141.1996.420960.x","article-title":"The impact of prophylactic treatment in children with severe haemophilia","volume":"92","author":"Liesner","year":"1996","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD003429.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","article-title":"Haemophilia prophylaxis in young patients - a long-term follow-up","volume":"241","author":"L\u00f6fqvist","year":"1997","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.2830470209","article-title":"Results of secondary prophylaxis in children with severe hemophilia","volume":"47","author":"Manco-Johnson","year":"1994","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2516.2006.01412.x","article-title":"Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia A","volume":"13","author":"Nemes","year":"2007","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0023|cit23","first-page":"111","article-title":"Our experience in Sweden with prophylaxis on haemophilia","volume":"34","author":"Nilsson","year":"1970","journal-title":"Bibliotheca Hematologica"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1651-2227.1976.tb16525.x","article-title":"Hemophilia prophylaxis in Sweden","volume":"65","author":"Nilsson","year":"1976","journal-title":"Acta Paediatrica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty-five years experience of prophylactic treatment in severe haemophilia A and B","volume":"232","author":"Nilsson","year":"1992","journal-title":"Journal of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003429.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00043426-199123000-00006","article-title":"Prophylaxis with factor concentrates in preventing hemophilic arthropathy","volume":"13","author":"Petrini","year":"1991","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2516.2001.00471.x","article-title":"What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?","volume":"7","author":"Petrini","year":"2001","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1651-2227.1981.tb05741.x","article-title":"Radiologic evaluation of prophylaxis in severe haemophilia","volume":"70","author":"Pettersson","year":"1981","journal-title":"Acta Paediatric of Scandinavia"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/jcp.26.4.243","article-title":"A trial of prophylactic replacement therapy in haemophilia and Christmas disease","volume":"26","author":"Ramsay","year":"1973","journal-title":"Journal of Clinical Pathology"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2516.2002.00581.x","article-title":"Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients","volume":"8","author":"Royal","year":"2002","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0031|cit31","first-page":"1979","article-title":"Hemophilia A prophylaxis with factor VIII concentrate in a home-treatment program: a controlled study","volume":"30","author":"Schimpf","year":"1977","journal-title":"Scandinavian Journal of Haematology. Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1160\/TH07-06-0417","article-title":"Effect of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A","volume":"99","author":"Schobess","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD003429.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-3476(96)70076-8","article-title":"Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis","volume":"129","author":"Smith","year":"1996","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2516.1996.tb00139.x","article-title":"Socioeconomic impact of haemophilia care: results of a pilot study","volume":"2","author":"Szucs","year":"1996","journal-title":"Haemophilia"},{"issue":"5","key":"10.1002\/14651858.CD003429.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2516.2008.01791.x","article-title":"Effect of secondary prophylaxis started in adult and haemophiliacs","volume":"14","author":"Tagliaferri","year":"2008","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/14651858.CD003429.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2516.2002.00619.x","article-title":"Prophylaxis in developed and in emerging countries","volume":"8","author":"Tusell","year":"2002","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/14651858.CD003429.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2141.2001.02580.x","article-title":"Long-term outcome of individualized prophylactic treatment of children with severe haemophilia","volume":"112","author":"Berg","year":"2001","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2516.2010.02348.x","article-title":"Low dose secondary prophylaxis reduces joint and severe bleeding in severe and moderate hemophilia children: A pilot study in China","volume":"17","author":"Wu","year":"2011","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003429.pub4-BIB0039|cit39","first-page":"7","article-title":"Haemophilia in Sweden VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B","volume":"77","author":"Ahlberg","year":"1965","journal-title":"Acta Orthopedic Scandinavian"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003429.pub4-BIB0040|cit40","first-page":"1","article-title":"Consensus perspectives in prophylactic therapy for haemophilia: summary statement","volume":"9","author":"Berntorp","year":"2000","journal-title":"Haemophilia"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003429.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2516.2004.00998.x","article-title":"Optimizing factor prophylaxis for the haemophilia population: where do we stand?","volume":"10","author":"Blanchette","year":"2004","journal-title":"Haemophilia"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1538-7836.2009.03703.x","article-title":"Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens","volume":"8","author":"Collins","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0043|cit43","unstructured":"Deeks J Higgins J Altman D Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2516.2003.00764.x","article-title":"Prophylaxis for severe haemophilia:clinical and economical issues","volume":"9","author":"Fisher","year":"2003","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003429.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2516.2007.01500.x","article-title":"Prophylaxis in adults with haemophilia","volume":"13","author":"Hay","year":"2007","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0046|cit46","first-page":"187","article-title":"Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"[updated March 2011]"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-3101(22)00847-7","article-title":"Hemophilic arthropathy","volume":"21","author":"Hilgartner","year":"1974","journal-title":"Advances in Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2516.2009.02122.x","article-title":"New early prophylaxis regimen that avoids immunological danger signals can reduceFVIII inhibitor development","volume":"16","author":"Kurnik","year":"2010","journal-title":"Haemophilia"},{"issue":"6","key":"10.1002\/14651858.CD003429.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2516.2000.00427.x","article-title":"Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries","volume":"6","author":"Ljiung","year":"2000","journal-title":"Haemophilia"},{"issue":"1","key":"10.1002\/14651858.CD003429.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1055\/s-0038-1657619","article-title":"Prophylaxis in children with hemophilia: is it the optimal treatment?","volume":"78","author":"Lusher","year":"1997","journal-title":"Thrombosis Haemostasis"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0051|cit51","unstructured":"National Hemophilia Foundation. MASAC MASAC recommendation concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding) www.hemophilia.org\/NHFWeb\/MainPgs\/MainNHF.aspx?menuid=57&contentid=582"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003429.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1355-0691.2004.00880.x","article-title":"Setting research priorities to improve cost-effectiveness estimations of primary prophylaxis with clotting factor for people with severe haemophilia A","volume":"10","author":"Miners","year":"2004","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/14651858.CD003429.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2516.2009.02019.x","article-title":"Revisiting the cost-effectiveness of primary prophylaxis with clotting factor for the treatment of severe haemophilia A","volume":"15","author":"Miners","year":"2009","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0054|cit54","unstructured":"The National Hemophilia Foundation Medical and Scientific Advisory Council recommendations concerning prophylaxis [abstract] Medical Bulletin 1994"},{"key":"10.1002\/14651858.CD003429.pub4-BIB0055|cit55","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"2","key":"10.1002\/14651858.CD003429.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2516.2003.00853.x","article-title":"Home care management of haemophilia","volume":"10","author":"Teitel","year":"2004","journal-title":"Haemophilia"},{"issue":"S2","key":"10.1002\/14651858.CD003429.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1351-8216.2001.00120.x","article-title":"Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies","volume":"8","author":"Berg","year":"2002","journal-title":"Haemophilia"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003429.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003429.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T02:41:42Z","timestamp":1686278502000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003429.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,7]]},"references-count":57,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003429.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,7]]}}}